Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05455086 · ClinicalTrials.gov registry record · NA
Free-Base Nicotine or Nicotine Salt e-Liquids in Current E-Cigarette Smokers, PeloPET Study
A NA study, sponsored by Ohio State University Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT05455086 is a NA study that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 21 participants.
The verdict
NCT05455086, a NA study, has completed, sponsored by Ohio State University Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
This clinical trial studies the effect of free-base compared with nicotine salt based e-liquids on electronic cigarette (EC) puffing behavior, abuse liability, and deposition and absorption of nicotine in the respiratory tract and rate of uptake in the brain in current EC smokers. The results from this study may provide much needed scientific information to public health officials and regulators.
Interventions
- PROCEDURE Computed Tomography
- BEHAVIORAL Cigarette Smoking
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2022-03-23 |
| Est. Completion | 2023-06-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05455086
The ClinicalTrials.gov registry entry for NCT05455086 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Computed Tomography is the first listed.
NCT05455086 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05455086 about?
NCT05455086 is a clinical study titled "Free-Base Nicotine or Nicotine Salt e-Liquids in Current E-Cigarette Smokers, PeloPET Study". This clinical trial studies the effect of free-base compared with nicotine salt based e-liquids on electronic cigarette (EC) puffing behavior, abuse liability, and deposition and absorption of nicotine in the respiratory tract and rate of uptake in the brain in current EC smokers. The results from t...
What is the current status of trial NCT05455086?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2022-03-23. Estimated completion is 2023-06-26.
What interventions are being tested in trial NCT05455086?
The interventions under investigation include: Computed Tomography (PROCEDURE), Cigarette Smoking (BEHAVIORAL).
Who is sponsoring clinical trial NCT05455086?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.